financetom
Business
financetom
/
Business
/
Sabadell CEO rules out M&A defence against BBVA bid
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Sabadell CEO rules out M&A defence against BBVA bid
May 29, 2024 6:17 AM

By Jesús Aguado and Andres Gonzalez

MADRID/LONDON (Reuters) - Spain's Sabadell is not planning to try and buy a competitor as part of a potential defence strategy against rival BBVA's hostile takeover attempt, Chief Executive Officer Cesar Gonzalez-Bueno told Reuters. Spain's No. 2 lender BBVA this month stunned Spain by making the first hostile takeover attempt in Spanish banking since the 1980s, after Sabadell's board rejected an initial bid on the grounds it significantly undervalued the lender.

"We are not going to acquire anything. We are not going to sell TSB," Gonzalez-Bueno said, referring to British bank TSB, which Sabadell owns.

Acquiring rivals or selling off parts of a business can be a way for target companies to complicate hostile takeovers.

Under Spanish law, the governing body of a company subject to a hostile offer must remain passive and request shareholder approval before taking any action that can prevent the bid's success.

Rejecting BBVA's offer - which is also opposed by Spain's government - Sabadell says it will focus on its own growth prospects.

It wrote to retail shareholders - who own half of Spain's fourth-largest bank - this week as it starts the process of trying to convince its investors the lender is better off alone.

In the letter, Chairman Josep Oliu said the takeover process could run until late 2024 or to 2025 and that Sabadell had "excellent prospects".

Sabadell's shares have risen around 10% since the day before news of BBVA's bid broke while BBVA's have fallen about 9%, suggesting shareholders of both lenders are not entirely persuaded of the merits of the offer or whether it will succeed.

BBVA has offered an exchange ratio of one newly-issued BBVA share for every 4.83 Sabadell shares, a premium of 30% over April 29 closing prices that valued Sabadell at 12.23 billion euros.

That premium is now around 7%, valuing Sabadell at about 11.1 billion euros, according to Reuters calculations.

Sabadell, which enlisted Goldman Sachs and Morgan Stanley as advisors after the initial offer was announced, has limited options to ward off its bigger rival.

Gonzalez-Bueno said BBVA's offer could run into competition hurdles, predicting Spain's anti-trust watchdog, CNMC, could potentially force BBVA to carve out Sabadell's business lending money to small and medium-sized companies.

The CNMC declined to comment.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Exclusive-Whitestone REIT may face board challenge by hedge fund Emmett Investment, sources say
Exclusive-Whitestone REIT may face board challenge by hedge fund Emmett Investment, sources say
Aug 21, 2025
NEW YORK (Reuters) -Hedge fund Emmett Investment Management is gearing up for a possible board room fight at Whitestone REIT and may nominate directors to the shopping center operator's six-person board, two people familiar with the matter told Reuters. Emmett, a New York-based investment firm run by Alexander Rohr, has been a long-term investor in Houston-headquartered Whitestone and has expressed...
Astera Labs Insider Sold Shares Worth $3,461,184, According to a Recent SEC Filing
Astera Labs Insider Sold Shares Worth $3,461,184, According to a Recent SEC Filing
Aug 21, 2025
10:13 AM EDT, 08/21/2025 (MT Newswires) -- Michael Truett Tate, Chief Financial Officer, on August 18, 2025, sold 18,861 shares in Astera Labs ( ALAB ) for $3,461,184. Following the Form 4 filing with the SEC, Tate has control over a total of 259,512 common shares of the company, with 259,512 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1736297/000173629725000114/xslF345X05/wk-form4_1755736017.xml Price: 177.65, Change:...
AbbVie's Patch Baldness Study Finds High Hair Coverage Rates With Investigational Drug Upadacitinib
AbbVie's Patch Baldness Study Finds High Hair Coverage Rates With Investigational Drug Upadacitinib
Aug 21, 2025
AbbVie Inc. ( ABBV ) on Thursday released topline results from the second of two pivotal studies of the Phase 3 UP-AA clinical program evaluating the safety and efficacy of upadacitinib (RINVOQ; 15 mg and 30 mg, once daily) in adult and adolescent patients with severe alopecia areata (AA) with a mean baseline SALT score of 84.0 (approximately 16% scalp...
Reddit Insider Sold Shares Worth $7,837,383, According to a Recent SEC Filing
Reddit Insider Sold Shares Worth $7,837,383, According to a Recent SEC Filing
Aug 21, 2025
10:11 AM EDT, 08/21/2025 (MT Newswires) -- Jennifer L. Wong, Chief Operating Officer, on August 18, 2025, sold 32,379 shares in Reddit ( RDDT ) for $7,837,383. Following the Form 4 filing with the SEC, Wong has control over a total of 1,556,628 Class A common shares of the company, with 1,395,628 shares held directly and 161,000 controlled indirectly. SEC...
Copyright 2023-2026 - www.financetom.com All Rights Reserved